The overexpression of HAb18G/CD147 has been proven to promote the migration of liver cancer cells by increasing the expression of integrin α3β1 and activating the integrin-FAK signaling pathway to increase the expression of paxillin [53]. This evidence concerns the gene PXN and liver cancer.